James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $569.71 ($5.8M) on 2026-05-07, disclosed to the SEC on 2026-05-11.
Scheduled sale ($5.8M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $569.71 | 560 | $319K | 5.5% |
| 2 | $571.77 | 560 | $320K | 5.5% |
| 3 | $572.93 | 807 | $462K | 8.0% |
| 4 | $573.94 | 1,306 | $750K | 13.0% |
| 5 | $575.14 | 1,045 | $601K | 10.4% |
| 6 | $575.98 | 1,002 |
| $577K |
| 10.0% |
| 7 | $577.42 | 640 | $370K | 6.4% |
| 8 | $578.65 | 520 | $301K | 5.2% |
| 9 | $580.37 | 399 | $232K | 4.0% |
| 10 | $581.50 | 281 | $163K | 2.8% |
| 11 | $583.41 | 200 | $117K | 2.0% |
| 12 | $584.21 | 400 | $234K | 4.0% |
| 13 | $585.83 | 640 | $375K | 6.5% |
| 14 | $586.73 | 340 | $199K | 3.4% |
| 15 | $587.74 | 700 | $411K | 7.1% |
| 16 | $589.02 | 320 | $188K | 3.3% |
| 17 | $589.72 | 120 | $71K | 1.2% |
| 18 | $597.54 | 160 | $96K | 1.7% |
| Total | $578.58 avg | 10,000 | $5.8M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |